申请人:Yamada Rintaro
公开号:US08415372B2
公开(公告)日:2013-04-09
A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, and the like; G3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, and the like; G4 represents hydroxyl group, or —N(R1)(R2) (R1 and R2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, or a saturated heterocyclic group); G5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits Rho kinase.
化合物的
化学式为(1) [其中A代表含氮饱和环;m表示0到2的整数;n表示1到4的整数;G1表示氢原子、
氯原子、羟基、烷氧基或
氨基;G2表示卤素原子、羟基、
氰基、羧基、烷基、烯基等;G3表示氢原子、卤素原子、羟基、
氰基、羧基、烷基、烯基等;G4表示羟基,或—N(R1)(R2)(R1和R2表示氢原子、烷基、
芳烃基、烯基、炔基或饱和杂环基);G5为A环中构成环的碳原子上的取代基,表示氢原子、
氟原子或烷基]或其盐,或是药物前体的衍
生物,能够有效抑制Rho激酶。